Clinical applications of hormonal therapy in ovarian cancer.
- Published in:
- Current Treatment Options in Oncology, 2005, v. 6, n. 2, p. 97, doi. 10.1007/s11864-005-0017-y
- By:
- Publication type:
- Article
Works matching IS 15272729 AND DT 2005 AND VI 6 AND IP 2
Results: 7
1
2
Rationale and clinical experience with epidermal growth factor receptor inhibitors in gynecologic malignancies.
- Published in:
- Current Treatment Options in Oncology, 2005, v. 6, n. 2, p. 103, doi. 10.1007/s11864-005-0018-x
- By:
- Publication type:
- Article
3
Incorporating new imaging models in breast cancer management.
- Published in:
- Current Treatment Options in Oncology, 2005, v. 6, n. 2, p. 135, doi. 10.1007/s11864-005-0021-2
- By:
- Publication type:
- Article
4
Targeted therapies for gynecologic malignancies.
- Published in:
- Current Treatment Options in Oncology, 2005, v. 6, n. 2, p. 121, doi. 10.1007/s11864-005-0020-3
- By:
- Publication type:
- Article
5
Imatinib mesylate and its potential implications for gynecologic cancers.
- Published in:
- Current Treatment Options in Oncology, 2005, v. 6, n. 2, p. 115, doi. 10.1007/s11864-005-0019-9
- By:
- Publication type:
- Article
6
Utilizing prognostic and predictive factors in breast cancer.
- Published in:
- Current Treatment Options in Oncology, 2005, v. 6, n. 2, p. 147, doi. 10.1007/s11864-005-0022-1
- By:
- Publication type:
- Article
7
Management of bone metastases in breast cancer.
- Published in:
- Current Treatment Options in Oncology, 2005, v. 6, n. 2, p. 161, doi. 10.1007/s11864-005-0023-0
- By:
- Publication type:
- Article